Viewing Study NCT06347757



Ignite Creation Date: 2024-05-06 @ 8:20 PM
Last Modification Date: 2024-10-26 @ 3:25 PM
Study NCT ID: NCT06347757
Status: COMPLETED
Last Update Posted: 2024-04-30
First Post: 2024-03-29

Brief Title: A 3-Arm Study Comparing the Efficacy of Anti-Reflux Reconstruction Protocols After Laparoscopic Proximal Gastrectomy
Sponsor: Northern Jiangsu Peoples Hospital
Organization: Northern Jiangsu Peoples Hospital

Study Overview

Official Title: A 3-Arm Study Comparing the Efficacy of Anti-Reflux Alimentary Reconstruction Protocols Single-Tract Jejunal Interposition vs Double Tract vs Tube-Like Stomach Reconstruction After Laparoscopic Proximal Gastrectomy
Status: COMPLETED
Status Verified Date: 2024-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The efficacy of three different alimentary reconstruction methods after proximal gastrectomy will be investigated in this study in a prospective multicenter randomized controlled trial
Detailed Description: In the trial 180 patients with early upper-third early gastric cancer and Siewert type IIIII esophagogastric junction cancer will be enrolled and then randomly assigned to one of three groups Group A single-tract jejunal interposition n 60 Group B double-tract reconstruction n 60 or Group C tube-like stomach reconstruction n 60 The primary co-end points were the incidence of reflux esophagitis at 2 years postoperatively The secondary end points included the incidence of anastomotic leakage and anastomotic stenosis operative time intraoperative blood loss quality of life overall survival and disease-free survival Quality of life outcomes were assessed using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire EORTC QLQ 30-item core questionnaire C30 and the EORTC QLQ stomach cancer-specific questionnaire at 3 months 12 months and 24 months

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None